TASK-3 channel deletion in mice recapitulates low-renin essential hypertension
- PMID: 22493079
- PMCID: PMC3357084
- DOI: 10.1161/HYPERTENSIONAHA.111.189662
TASK-3 channel deletion in mice recapitulates low-renin essential hypertension
Erratum in
- Hypertension. 2012 Jun;59(6):e59
Abstract
Idiopathic primary hyperaldosteronism (IHA) and low-renin essential hypertension (LREH) are common forms of hypertension, characterized by an elevated aldosterone-renin ratio and hypersensitivity to angiotensin II. They are suggested to be 2 states within a disease spectrum that progresses from LREH to IHA as the control of aldosterone production by the renin-angiotensin system is weakened. The mechanism(s) that drives this progression remains unknown. Deletion of Twik-related acid-sensitive K(+) channels (TASK) subunits, TASK-1 and TASK-3, in mice (T1T3KO) produces a model of human IHA. Here, we determine the effect of deleting only TASK-3 (T3KO) on the control of aldosterone production and blood pressure. We find that T3KO mice recapitulate key characteristics of human LREH, salt-sensitive hypertension, mild overproduction of aldosterone, decreased plasma-renin concentration with elevated aldosterone:renin ratio, hypersensitivity to endogenous and exogenous angiotensin II, and failure to suppress aldosterone production with dietary sodium loading. The relative differences in levels of aldosterone output and aldosterone:renin ratio and in autonomy of aldosterone production between T1T3KO and T3KO mice are reminiscent of differences in human hypertensive patients with LREH and IHA. Our studies establish a model of LREH and suggest that loss of TASK channel activity may be one mechanism that advances the syndrome of low renin hypertension.
Figures





Similar articles
-
Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system.Endocrinology. 2013 Aug;154(8):2712-22. doi: 10.1210/en.2013-1101. Epub 2013 May 22. Endocrinology. 2013. PMID: 23698720
-
Adrenal Tissue-Specific Deletion of TASK Channels Causes Aldosterone-Driven Angiotensin II-Independent Hypertension.Hypertension. 2019 Feb;73(2):407-414. doi: 10.1161/HYPERTENSIONAHA.118.11962. Hypertension. 2019. PMID: 30580687 Free PMC article.
-
TASK channel deletion in mice causes primary hyperaldosteronism.Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2203-8. doi: 10.1073/pnas.0712000105. Epub 2008 Feb 4. Proc Natl Acad Sci U S A. 2008. PMID: 18250325 Free PMC article.
-
Hypertension: renin-angiotensin-aldosterone system alterations.Circ Res. 2015 Mar 13;116(6):960-75. doi: 10.1161/CIRCRESAHA.116.303587. Circ Res. 2015. PMID: 25767283 Review.
-
[New data on mineralocorticoid hormones. Physiopathological implications].Presse Med. 1995 Sep 23;24(27):1235-7. Presse Med. 1995. PMID: 7501603 Review. French.
Cited by
-
Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production: an exploratory study.J Clin Endocrinol Metab. 2012 Nov;97(11):E2160-7. doi: 10.1210/jc.2012-2196. Epub 2012 Aug 14. J Clin Endocrinol Metab. 2012. PMID: 22893713 Free PMC article.
-
Low sodium intake ameliorates hypertension and left ventricular hypertrophy in mice with primary aldosteronism.Front Physiol. 2023 Feb 15;14:1136574. doi: 10.3389/fphys.2023.1136574. eCollection 2023. Front Physiol. 2023. PMID: 36875038 Free PMC article.
-
Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation.Nat Commun. 2019 Nov 14;10(1):5155. doi: 10.1038/s41467-019-13033-4. Nat Commun. 2019. PMID: 31727896 Free PMC article.
-
Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonation.J Clin Invest. 2020 Jan 2;130(1):83-93. doi: 10.1172/JCI127429. J Clin Invest. 2020. PMID: 31738186 Free PMC article.
-
Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?Endocrinology. 2014 Jan;155(1):47-55. doi: 10.1210/en.2013-1733. Epub 2013 Dec 20. Endocrinology. 2014. PMID: 24248457 Free PMC article. Review.
References
-
- Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF, Jr, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266–3281. - PubMed
-
- Gordon RD, Laragh JH, Funder JW. Low renin hypertensive states: Perspectives, unsolved problems, future research. Trends Endocrinol Metab. 2005;16:108–113. - PubMed
-
- Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf) 2007;67:324–334. - PubMed
-
- Stowasser M, Gordon RD. The aldosterone-renin ratio and primary aldosteronism. Mayo Clin Proc. 2002;77:202–203. - PubMed
-
- Tomaschitz A, Maerz W, Pilz S, Ritz E, Scharnagl H, Renner W, Boehm BO, Fahrleitner-Pammer A, Weihrauch G, Dobnig H. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol. 2010;55:2171–2180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases